Treatment of acute promyelocytic leukemia by retinoic acid with or without low dose cytosine arabinoside: report of 4 cases
Huang, M.E.; Ye, Y.C.; Zhao, L.
Zhonghua Nei Ke Za Zhi 26(6): 330
1987
ISSN/ISBN: 0578-1426 PMID: 3477416 Document Number: 292818
Document emailed within 1 workday
Related Documents
Chen, G.Q.; Shen, Z.X.; Wu, F.; Han, J.Y.; Miao, J.M.; Zhong, H.J.; Li, X.S.; Zhao, J.Q.; Zhu, J.; Fang, Z.W.; Chen, S.J.; Chen, Z.; Wang, Z.Y. 1996: Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia Leukemia 10(5): 825-828Fukutani, H.; Naoe, T.; Ohno, R.; Yoshida, H.; Miyawaki, S.; Shimazaki, C.; Miyake, T.; Nakayama, Y.; Kobayashi, H.; Goto, S. 1995: Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. the Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho) Leukemia 9(9): 1478-1482
Sun, G.L. 1993: Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience Zhonghua Zhong Liu Za Zhi 15(2): 125-129
Pedersen, G.; Stentoft, J.; Pedersen, J.O.; Jensen, M.K. 1994: Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside Ugeskrift for Laeger 156(43): 6380-6384
Kobayashi, S.; Sakai, H.; Tomiazwa, T.; Koiso, H.; Kim, K.; Ueki, K.; Tamura, J.; Yano, S.; Naruse, T.; Karasawa, M. 1999: Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis Journal of Medicine 30(1-2): 101-109
Huang, M.E. 1988: Treatment of acute promyelocytic leukemia with all-trans retinoic acid Zhonghua Yi Xue Za Zhi 68(3): 131-133; 10
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Wang, Z.Y.; Sun, G.L.; Lu, J.X.; Gu, L.J.; Huang, M.E.; Chen, S.R. 1990: Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China Nouvelle Revue Francaise d'Hematologie 32(1): 34-36
Maschan, A.A.; Klebanova, N.G.; Miakova, N.V.; Tiganova, O.A.; Timakov, A.M.; Samochatova, E.V. 1996: Treatment of acute promyelocytic leukemia in children with all-trans-retinoic acid Gematologiia i Transfuziologiia 41(2): 43-45
Sun, G.L.; Ouyang, R.R.; Chen, S.J.; Gu, Y.Z.; Huang, L.A.; Lu, J.X.; Wang, Z.Y. 1993: Treatment of acute promyelocytic leukemia with all-trans retinoic acid. a five-year experience Chinese Medical Journal 106(10): 743-748
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Ghaddar, H.M.; Plunkett, W.; Kantarjian, H.M.; Pierce, S.; Freireich, E.J.; Keating, M.J.; Estey, E.H. 1994: Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside Leukemia 8(8): 1269-1274
Lin, S.F.; Liu, H.W.; Chen, T.P. 1990: Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C) Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 53(1): 45-50
Simzar, S.; Rotunda, A.M.; Craft, N. 2005: Scrotal ulceration as a consequence of all-trans-retinoic acid (ATRA) for the treatment of acute promyelocytic leukemia Journal of Drugs in Dermatology: Jdd 4(2): 231-232
Ohshima, A.; Yoshida, K.; Sato, T.; Miyazaki, S.; Yanagisawa, M.; Nakayama, Y.; Takahashi, T.; Mamiya, S.; Fukusima, Y.; Miura, A.B. 1987: Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(1): 192-195
Wakita, A.; Murase, T.; Uchida, T.; Fujiwara, Y.; Tanaka, M.; Ohkita, T. 1992: Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(5): 653-657
Wysocki, M.; Nowaczyk-Michalak, A.; Pilecki, O.; Trybuś, L.; Balcar-Boroń, A. 1992: Jaundice following high--dose arabinoside cytosine in a child with acute myelogenous leukemia Acta Haematologica Polonica 23(3): 197-199
Cornic, M.; Delva, L.; Castaigne, S.; Lefebvre, P.; Balitrand, N.; Degos, L.; Chomienne, C. 1994: In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia Leukemia 8(Suppl): S16-S19
Klener, P.; Háber, J. 1985: Treatment of refractory leukemia with high-dose cytosine arabinoside Neoplasma 32(1): 113-117
Fenaux, P.; Chastang, C.; Degos, L. 1994: Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group Leukemia 8(Suppl 2): S42-S47